To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Pregnancy Hormone May Help Fight HIV URL: http://www.pslgroup.com/dg/22E6E.htm Doctor's Guide April 2, 1997
Bethesda, MD --April 2, 1997 -- An animal study at the National Institutes of Health has produced intriguing evidence that a pregnancy hormone may protect the developing fetus from the ravages of the human immunodeficiency virus, HIV. The study also points to a potential role for the hormone in fighting HIV-related wasting. The hormone in question is human chorionic gonadotropin (hCG). Normally produced by the placenta to help maintain pregnancy, hCG is the hormone that produces a positive pregnancy test. The possible connection between hCG and HIV was studied in a special strain of transgenic mice. The mice had been engineered to ontain an incomplete set of HIV genes in the DNA of every cell in their bodies. The virus could not reproduce, but could trick certain mouse cells into making many of the viral proteins. Baby mice that inherit HIV DNA from each transgenic parent eventually accumulate enough viral protein that they develop skin lesions, wasting syndrome, and die within 3 to 6 weeks. However, when the mice were treated with hCG, the majority of the animals showed normal weight gain as long as they were receiving the hormone. Furthermore, their cells produced considerably less viral protein than animals not receiving hormone treatment, and skin lesions were dramatically reduced. The study appears in the April 2 issue of The Journal of Clinical Investigation. The results of this study could have implications in treating human HIV infection, according to Dr. Abner Notkins, who directed the search at the National Institute of Dental Research (NIDR). "Human chorionic gonadotropin may be another weapon to use against HIV," said Dr. Notkins. "The hormone may explain the relatively low rate of HIV transmission from mother to infant, and also could have potential for treating HIV-associated wasting syndrome in children and adults." Dr. Notkins and his colleagues first recognized that maternal hormones might have a protective effect against HIV when they observed that newborn transgenic mice appear normal in size and weight, but soon show marked growth retardation. By 8 days of age they weigh 60 percent less that their normal littermates. It appeared to the investigators that the baby mice were protected by maternal hormones during pregnancy, and became susceptible to the effects of HIV once the level of hormones dropped dramatically at birth. Scientists still don't know the exact mechanism by which hCG inhibits HIV. However, the NIDR results support test tube studies from other laboratories, which showed that hCG or its beta subunit could lower production of the viral proteins and block cell-to-cell transmission of HIV. The beta subunit has even been shown to kill Kaposi's sarcoma cells in the laboratory and prevent these cells from producing tumors in mice. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.